| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Duchenne Muscular Dystrophy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Muscular Dystrophies | |||||
| Muscular Dystrophy, Duchenne | |||||
| 3 | More general conditions related to this trial | ||||
| Genetic Diseases, Inborn | |||||
| Genetic Diseases, X-Linked | |||||
| Muscular Diseases | |||||
| Muscular Disorders, Atrophic | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Prednisone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Cooperative International Neuromuscular Research Group | |||||
|
